全文获取类型
收费全文 | 2095篇 |
免费 | 88篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 82篇 |
妇产科学 | 52篇 |
基础医学 | 255篇 |
口腔科学 | 151篇 |
临床医学 | 351篇 |
内科学 | 323篇 |
皮肤病学 | 132篇 |
神经病学 | 165篇 |
特种医学 | 33篇 |
外国民族医学 | 1篇 |
外科学 | 142篇 |
综合类 | 17篇 |
一般理论 | 1篇 |
预防医学 | 234篇 |
眼科学 | 19篇 |
药学 | 82篇 |
中国医学 | 1篇 |
肿瘤学 | 120篇 |
出版年
2023年 | 15篇 |
2022年 | 16篇 |
2021年 | 17篇 |
2020年 | 25篇 |
2019年 | 39篇 |
2018年 | 30篇 |
2017年 | 39篇 |
2016年 | 45篇 |
2015年 | 50篇 |
2014年 | 79篇 |
2013年 | 141篇 |
2012年 | 103篇 |
2011年 | 146篇 |
2010年 | 69篇 |
2009年 | 70篇 |
2008年 | 141篇 |
2007年 | 138篇 |
2006年 | 111篇 |
2005年 | 113篇 |
2004年 | 112篇 |
2003年 | 120篇 |
2002年 | 103篇 |
2001年 | 19篇 |
2000年 | 15篇 |
1999年 | 17篇 |
1998年 | 23篇 |
1997年 | 23篇 |
1996年 | 23篇 |
1995年 | 42篇 |
1994年 | 24篇 |
1993年 | 23篇 |
1992年 | 12篇 |
1991年 | 16篇 |
1990年 | 18篇 |
1989年 | 5篇 |
1988年 | 18篇 |
1987年 | 12篇 |
1986年 | 20篇 |
1985年 | 11篇 |
1984年 | 15篇 |
1983年 | 15篇 |
1982年 | 15篇 |
1981年 | 12篇 |
1980年 | 9篇 |
1979年 | 9篇 |
1978年 | 5篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1975年 | 5篇 |
1974年 | 7篇 |
排序方式: 共有2185条查询结果,搜索用时 15 毫秒
991.
Filip Mundt Magali Merrien Lina Nygren Lesley A. Sutton Birger Christensson Björn E. Wahlin Richard Rosenquist Birgitta Sander Agata M. Wasik 《British journal of haematology》2019,185(4):708-712
Mantle cell lymphoma (MCL), a malignancy of B-lymphocytes, has a poor prognosis. It is thus necessary to improve the understanding of the pathobiology of MCL and identify factors contributing to its aggressiveness. Our studies, based on Affymetrix data from 17 MCL biopsies, real-time quantitative polymerase chain reaction data from 18 sorted primary MCL cells and 108 MCL biopsies compared to non-malignant tissue, reveals that GNAZ expression predicts poor clinical outcome of MCL patients (Cox regression, P = 0·014) and lymphocytosis (Mann-Whitney, P = 0·011). We show that GNAZ translates to Gαz protein – a signalling molecule within the G-protein coupled receptor network. Our findings suggest that GNAZ/Gαz contribute to the MCL pathobiology. 相似文献
992.
Rosén B Björkman A Lundborg G 《Journal of occupational medicine and toxicology (London, England)》2011,6(1):13
Objectives
We report a long-term series of nine workers suffering from vibration-induced neuropathy, after many years of exposure to hand-held vibrating tools at high or low frequency. They were treated with temporary selective cutaneous anaesthesia (EMLA? cream) of the forearm repeatedly for a period up to one year (in two cases four years). The aim was to improve their capacity to perceive touch and thereby improve hand function and diminish disability. The treatment principle is based on current concepts of brain plasticity, where a deafferentation of a skin area results in improved sensory function in adjacent skin areas. 相似文献993.
994.
Söder B Yakob M Meurman JH Andersson LC Klinge B Söder PÖ 《Breast cancer research and treatment》2011,127(2):497-502
The main purpose was to evaluate the association between periodontal disease and the incidence of breast cancer in a prospective
study of 3273 randomly selected subjects aged 30–40 years at baseline. Breast cancer incidence was registered from 1985 to
2001 according to the WHO International Classification of Diseases criteria. At baseline, 1676 individuals also underwent
a clinical oral examination (Group A) whereas 1597 subjects were not clinically examined but were registered (Group B). The
associations between breast cancer, periodontal disease, and missing molars were determined using multiple logistic regression
models with several background variables and known risk factors for cancer. In total 26 subjects in group A and 15 subjects
in group B had breast cancer. The incidence of breast cancer was 1.75% in subjects who had periodontal disease and/or any
missing molars, and 0 in subjects who had periodontal disease but had no missing molars. For periodontally healthy subjects
with no missing teeth the breast cancer incidence was 1%. For group B the respective incidence was 0.94%. Female gender (odds
ratio (OR) 13.08) and missing any molar in the mandible (OR 2.36) were explanatory variables for breast cancer. Of the subjects
with periodontal disease and any missing molars in the mandible 5.5% had breast cancer in comparison to 0.5% of the subjects
who had periodontal disease but no missing molars in the mandible (P < 0.02). Chronic periodontal disease indicated by missing molars seemed to associate statistically with breast cancer. 相似文献
995.
Clinchy B Fransson A Druvefors B Hellsten A Håkansson A Gustafsson B Sjödahl R Håkansson L 《Cancer》2007,109(9):1742-1749
BACKGROUND: Colorectal cancer is one of the most common forms of cancer in the Western world. Staging based on histopathology is currently the most accurate predictor of outcome after surgery. Colorectal cancer is curable if treated at an early stage (stage I-III). However, for tumors in stages II and III there is a great need for tests giving more accurate prognostic information defining the patient population in need of closer follow-up and/or adjuvant therapy. Furthermore, tests that provide prognostic information preoperatively could provide a guide both for preoperative oncologic treatment and the surgical procedure. METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated preoperatively, within a week before primary surgery, from 39 patients undergoing surgery for colorectal cancer. The PBMCs were cultured in vitro for 24 hours in the presence of autologous serum and lipopolysaccharide (LPS). Interleukin-6 (IL-6) production was measured with enzyme-linked immunosorbent assay (ELISA). Staging based on histopathology was performed in all patients. Patients were followed for at least 54 months. RESULTS: A production of >5000 pg/mL of IL-6 identified colorectal cancer patients with a poor prognosis. Eight out of 13 patients with >5000 pg/mL IL-6 died from cancer within the follow-up period, whereas no cancer-related deaths were recorded among 21 patients with 5000 pg/mL IL-6 or less. A multivariate Cox regression analysis, stratified for T- and N-stage, identified IL-6 production as an independent prognostic factor. CONCLUSIONS: IL-6 production in vitro by PBMC can predict survival after radical surgery for colorectal cancer. 相似文献
996.
This study explored parents' perceptions of the service quality of two intensive training programmes and the association between perceived service quality and predefined influential factors. Parents of 31 males and 19 females with spastic, dyskinetic, and ataxic cerebral palsy (mean age 8 y 7 mo [SD 3 y 7 mo]; range 3-16 y), and Gross Motor Function Classification System Level I n=1; Level II n=9; Level III n=8; Level IV n=20; and Level V n=12 were included. Functional outcome had been evaluated previously with the clinical measures Gross Motor Function Measure-88, the Pediatric Evaluation of Disability Inventory-Functional Skills, and the Self-reported Individualized Goal Measure, before and after a 4-week intensive training period (ITP). The two training programmes used were Lemo and Move&Walk. After the ITP, a telephone interview was performed with the same cohort, using the Patient perspective On Care and Rehabilitation process. Data on previous experiences, expectations, and severity of disability were collected before the ITP, and data on achieved expectations afterwards. Previous experiences of the training programme, high expectations of improvements, achieved expectations, gross motor capacity improvements, and intensive training at the child and youth rehabilitation centre were associated with increased probability of fulfillment of needs. Severity of disability was associated with decreased probability of fulfillment of needs and functional improvements. Most parents perceived high service quality, and achieved expectations were influenced by high service quality rather than by perceived functional improvements. This suggests that needs other than functional improvements must be explained and acknowledged. 相似文献
997.
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis 总被引:7,自引:0,他引:7
Gunnarsson I Sundelin B Jónsdóttir T Jacobson SH Henriksson EW van Vollenhoven RF 《Arthritis and rheumatism》2007,56(4):1263-1272
OBJECTIVE: Rituximab is a monoclonal antibody directed against the CD20 marker of B cells. Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be of benefit in B cell-dependent diseases, including systemic lupus erythematosus (SLE). The purpose of this study was to investigate the histopathologic and clinical effects of combination treatment with rituximab and cyclophosphamide (CYC) in patients with CYC-resistant proliferative lupus nephritis. METHODS: Seven female patients with proliferative lupus nephritis were treated with rituximab in combination with CYC. Renal biopsies were performed before treatment and during followup. SLE activity was evaluated by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and the British Isles Lupus Assessment Group index. In 6 of the 7 patients, immunostaining of lymphocyte subpopulations in the renal tissue was performed before treatment and during followup. RESULTS: At 6 months of followup, significant clinical improvement was noted, with a reduction in SLEDAI scores (from a mean of 15 to 3), anti-double-stranded DNA antibody levels (from a mean of 174 IU/ml to 56 IU/ml), and anti-C1q antibody levels (from a mean of 35 units/ml to 22 units/ml). On repeat renal biopsy, improvement in the histopathologic class of nephritis occurred in a majority of patients, and a decrease in the renal activity index was noted (from 6 to 3). A reduction in the number of CD3, CD4, and CD20 cells in the renal interstitium was noted in 50% of the patients on repeat biopsy. CONCLUSION: At 6 months of followup, all patients had responded both clinically and histopathologically to combination therapy. For patients with proliferative lupus nephritis who fail to respond to conventional immunosuppressive therapy including CYC, combined treatment with rituximab and CYC may constitute a new treatment option. 相似文献
998.
Zhu C Xu F Fukuda A Wang X Fukuda H Korhonen L Hagberg H Lannering B Nilsson M Eriksson PS Northington FJ Björk-Eriksson T Lindholm D Blomgren K 《The European journal of neuroscience》2007,26(12):3402-3410
We demonstrate that X chromosome-linked inhibitor of apoptosis protein (XIAP) counteracts oxidative stress in two essentially different disease-related models of brain injury, hypoxia-ischemia and irradiation, as judged by lower expression of nitrotyrosine (5-fold) and 4-hydroxy-2-nonenal (10-fold) in XIAP-overexpressing compared with wild-type mice. XIAP overexpression induced up-regulation of at least three antioxidants residing in mitochondria, superoxide dismutase 2, thioredoxin 2 and lysine oxoglutarate reductase. Cytochrome c release from mitochondria was reduced in XIAP-overexpressing mice. Hence, in addition to blocking caspases, XIAP can regulate reactive oxygen species in the brain, at least partly through up-regulation of mitochondrial antioxidants. XIAP-induced prevention of oxidative stress was not secondary to tissue protection because although XIAP overexpression provides tissue protection after hypoxia-ischemia, it does not prevent tissue loss after irradiation. This is a previously unknown role of XIAP and may provide the basis for development of novel protective strategies for both acute and chronic neurodegenerative diseases, where oxidative stress is an integral component of the injury mechanisms involved. 相似文献
999.
Ekblom K Hultdin J Stegmayr B Johansson I Van Guelpen B Hallmans G Weinehall L Johansson L Wiklund PG Marklund SL 《Cerebrovascular diseases (Basel, Switzerland)》2007,24(5):405-411
BACKGROUND: High iron levels can increase the formation of noxious oxygen radicals, which are thought to contribute to cerebrovascular disease. The aim of this prospective study was to determine if iron status and HFE genotypes constitute risk factors for stroke. METHODS: First-ever stroke cases (231 ischemic and 42 hemorrhagic) and matched double referents from the population-based Northern Sweden cohorts were studied in a nested case-referent setting. RESULTS: For total iron binding capacity, an increased risk of ischemic stroke was seen in the highest quartile (OR 1.80; 95% CI 1.14-2.83; p for trend 0.012). The highest quartile of transferrin iron saturation showed a decreased risk of ischemic stroke in men (OR 0.44; 95% CI 0.22-0.87; p for trend 0.028), but not in women. There was an increased risk of hemorrhagic stroke in the second (OR 4.07; 95% CI 1.09-15.20) and third quartile (OR 4.22; 95% CI 1.08-16.42) of ferritin. Neither quartiles of plasma iron concentrations nor the HFE C282Y and H63D genotypes were associated with ischemic or hemorrhagic stroke. CONCLUSIONS: Iron stores were not positively related to increased risk of ischemic stroke. Furthermore, HFE genotypes did not influence the risk of ischemic or hemorrhagic stroke. 相似文献
1000.